Author:
Konst Matthew J.,Matson Johnny L.
Publisher
Springer International Publishing
Reference262 articles.
1. Accardo, J., Kammann, H., & Hoon, A. H. Jr. (2004). Neuroimaging in cerebral palsy. The Journal of Pediatrics, 145(2), 19–27.
2. Adair, B., Said, C. M., Rodda, J., & Morris, M. E. (2012). Psychometric properties of functional mobility tools in hereditary spastic paraplegia and other childhood neurological conditions. Developmental Medicine and Child Neurology, 54(7), 596–605.
3. Ade-Hall, R. A., & Moore, A. P. (2000). Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database of Systematic Reviews, 2000(2), CD001408.
4. Alonso, R. J., & Mancall, E. L. (1991). The clinical management of spasticity. Seminars in Neurology, 11(3), 215–219.
5. Anasari, N. N., Naghdi, S., Arab, T. K., & Jalaie, S. (2008a). The interrater and intrarater reliability of the modified ashworth scale in the assessment of muscle spasticity: Limb and muscle group effect. NeuroRehabilitation, 23(3), 231–237.